2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 11.789 | 46.773 | 40.996 | 51.364 | 47.627 | 59.822 |
Total Income - EUR | - | - | - | - | 11.789 | 46.827 | 41.076 | 51.479 | 49.411 | 61.131 |
Total Expenses - EUR | - | - | - | - | 263 | 1.235 | 1.933 | 2.549 | 2.722 | 13.315 |
Gross Profit/Loss - EUR | - | - | - | - | 11.526 | 45.593 | 39.143 | 48.930 | 46.688 | 47.816 |
Net Profit/Loss - EUR | - | - | - | - | 11.172 | 44.188 | 38.168 | 47.682 | 45.839 | 47.298 |
Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Oncofocus S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 1.608 | 767 | 279 | 487 | 0 | 0 | - | - | - | - |
Current Assets | - | - | - | - | 11.719 | 44.816 | 38.192 | 47.700 | 46.794 | 57.992 |
Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 36.638 | 0 |
Cash | - | - | - | - | 11.719 | 44.816 | 38.192 | 47.700 | 10.156 | 57.992 |
Shareholders Funds | - | - | - | - | 11.215 | 44.239 | 38.218 | 47.731 | 46.090 | 56.888 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 504 | 578 | 462 | 248 | 866 | 2.365 |
Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 605 | 347 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year | 8622 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.